Perceptive Advisors as of Dec. 31, 2010
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 63 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| D Alexion Pharmaceutic Als Inc C Common Stock 0 | 9.4 | $32M | 402k | 80.56 | |
| Cephalon | 9.0 | $31M | 500k | 61.72 | |
| Biogen Idec (BIIB) | 7.8 | $27M | 400k | 67.05 | |
| Allergan Inc Com Stk | 5.7 | $20M | 285k | 68.67 | |
| United Therapeutics Corporation (UTHR) | 5.0 | $17M | 270k | 63.22 | |
| Pharmacyclics | 5.0 | $17M | 2.8M | 6.08 | |
| Chelsea Therapeutics International | 4.0 | $14M | 1.8M | 7.50 | |
| Express Scripts | 3.8 | $13M | 240k | 54.05 | |
| Genzyme Corporation | 3.5 | $12M | 170k | 71.20 | |
| MannKind Corporation | 3.0 | $11M | 1.3M | 8.06 | |
| Salix Pharmaceuticals | 3.0 | $10M | 220k | 46.96 | |
| Human Genome Sciences | 2.9 | $10M | 422k | 23.89 | |
| Jazz Pharmaceuticals | 2.4 | $8.2M | 416k | 19.68 | |
| Celgene Corporation | 2.2 | $7.6M | 129k | 59.14 | |
| EXACT Sciences Corporation (EXAS) | 2.2 | $7.6M | 1.3M | 5.98 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $7.4M | 965k | 7.64 | |
| Progenics Pharmaceuticals | 1.9 | $6.4M | 1.2M | 5.46 | |
| BioMimetic Therapeutics | 1.9 | $6.4M | 501k | 12.70 | |
| Auxilium Pharmaceuticals | 1.8 | $6.3M | 300k | 21.10 | |
| Spdr S&p 500 Etf (SPY) | 1.8 | $6.3M | 50k | 125.76 | |
| AVI BioPharma ComStk Usd0.0001 | 1.6 | $5.4M | 2.6M | 2.12 | |
| Watson Pharmaceuticals | 1.5 | $5.2M | 100k | 51.65 | |
| Shire | 1.5 | $5.1M | 70k | 72.39 | |
| Teva Pharmaceutical Industries (TEVA) | 1.4 | $4.7M | 90k | 52.13 | |
| Uroplasty | 1.2 | $4.2M | 1.0M | 4.03 | |
| 3SBio (SSRX) | 1.2 | $4.1M | 271k | 15.18 | |
| Orexigen Therapeutics | 1.2 | $4.0M | 500k | 8.08 | |
| Gilead Sciences (GILD) | 1.2 | $4.0M | 110k | 36.24 | |
| Keryx Biopharmaceuticals | 1.1 | $3.8M | 823k | 4.58 | |
| ProAssurance Corporation (PRA) | 0.9 | $3.0M | 50k | 60.60 | |
| Capital Senior Living Corporation | 0.8 | $2.8M | 413k | 6.70 | |
| PDL BioPharma | 0.8 | $2.7M | 439k | 6.23 | |
| Endo Pharmaceuticals | 0.7 | $2.5M | 70k | 35.71 | |
| Warner Chilcott Plc - | 0.7 | $2.3M | 100k | 22.56 | |
| Incyte Corporation (INCY) | 0.6 | $2.0M | 120k | 16.56 | |
| UnitedHealth (UNH) | 0.5 | $1.8M | 50k | 36.12 | |
| Trinity Biotech | 0.5 | $1.7M | 192k | 8.80 | |
| Ym Biosciences | 0.5 | $1.6M | 690k | 2.33 | |
| Momenta Pharmaceuticals | 0.4 | $1.5M | 100k | 14.97 | |
| Sabra Health Care REIT (SBRA) | 0.4 | $1.3M | 72k | 18.40 | |
| Nektar Therapeutics | 0.4 | $1.3M | 100k | 12.85 | |
| Arena Pharmaceuticals | 0.3 | $1.0M | 600k | 1.72 | |
| Response Genetics (RGDXQ) | 0.3 | $1000k | 403k | 2.48 | |
| China Nuokang Bio-Pharmaceutical (NKBP) | 0.3 | $965k | 255k | 3.79 | |
| MAKO Surgical | 0.2 | $761k | 50k | 15.22 | |
| XenoPort | 0.2 | $639k | 75k | 8.52 | |
| Thoratec Corporation | 0.2 | $589k | 21k | 28.32 | |
| Palomar Medical Technologies | 0.2 | $568k | 40k | 14.20 | |
| Columbia Laboratories | 0.2 | $568k | 250k | 2.27 | |
| Immunomedics | 0.2 | $537k | 150k | 3.58 | |
| Raptor Pharmaceutical | 0.2 | $546k | 150k | 3.64 | |
| Ariad Pharmaceuticals | 0.1 | $510k | 100k | 5.10 | |
| Sun Healthcare Group | 0.1 | $527k | 42k | 12.65 | |
| Cynosure | 0.1 | $415k | 41k | 10.24 | |
| Stereotaxis | 0.1 | $287k | 75k | 3.83 | |
| LeMaitre Vascular (LMAT) | 0.1 | $271k | 40k | 6.78 | |
| Amarin Corporation | 0.1 | $246k | 30k | 8.20 | |
| athenahealth | 0.1 | $221k | 5.4k | 40.93 | |
| Osiris Therapeutics | 0.0 | $85k | 11k | 7.77 | |
| pSivida | 0.0 | $70k | 14k | 5.09 | |
| Santarus | 0.0 | $51k | 16k | 3.29 | |
| Nile Therapeutics Inc *w exp 99/99/999 | 0.0 | $42k | 150k | 0.28 | |
| Combimatrix Corporation *w exp 05/01/201 | 0.0 | $0 | 50k | 0.00 |
